In 2023 alone, 1.2 million Medicare beneficiaries had opioid use disorder and more than 53,000 experienced an overdose. As a spine surgeon dual board-certified in orthopedic surgery and addiction ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

Medicare Part B costs will rise in 2026. Here's what to expect, including higher prescription drug prices and payment changes ...

The law would require Medicare Part D plans to include lower‑cost generics when they are cheaper than brand‑name drugs.

Even if you are not on any prescriptions, it might be important to have Medicare Part D ...

The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from ...

Patients with Medicare Part D insurance plans experience uneven and “restrictive” coverage of certain drugs and drug classes ...

If you've been a Medicare enrollee for quite some time, you may be more than aware that your healthcare coverage isn't free.

You may be surprised to learn how much you can personally benefit from the closing of the donut hole.

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...

The pharmaceutical industry is entering an era of mega-blockbusters, drugs with annual sales of $10 billion or more, that ...